Skip to Main Content

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy (ARISE)

Conditions

Diseases of the Nervous System

Phase II

What is the purpose of this trial?

Brief Summary:

The purpose of the study is to characterize the dose-response relationship with respect to efficacy of Padsevonil administered concomitantly with up to 3 anti-epileptic drugs (AEDs) for treatment of observable focal-onset seizures in subjects with drug-resistant epilepsy.

  • Trial with
    UCB Biopharma
  • Start Date
    03/31/2019
  • End Date
    10/28/2019
Trial Image

For more information about this study, contact:

Judith Hess

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    07/01/2019
  • Study HIC
    #2000024790